Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
, the MRC CMM, DDU and GSK GHM form a dynamic and multidisciplinary group that covers all aspects of drug discovery up to candidate selection. This role has two key aspects. In the first instance, our goal is
-
to improve model simulation, and attribution of the impacts of SAI Design further AI/ML approach to test hypothesised mechanisms that emerge from the analysis Main Duties The responsibilities may include some
-
of Glasgow/Ifakara Health Institute) to develop and test new methods for trial design and analysis. Developing statistical models and code to run the proposed methods. Developing and running simulation-based
-
. Qualifications Please include a CV, cover letter, and contact information for 3 references in the application. A PhD, PhD-MD or doctoral equivalent in Cancer Biology, Epigenetics/Genetics, Molecular Biology
-
partners, including other Harvard Medical School-affiliated hospitals. The Fischer Lab at Dana-Farber Cancer Institute is a Structural and Chemical Biology lab that combines molecular biology, computational
-
collaboration with Open Targets and BioModels teams. The project Digital Twins are virtual representations of patients that simulate disease progression and treatment response. Rare diseases pose a unique
-
undergraduate (Bachelor’s/BSc) and postgraduate (Master’s/MSc) programmes, mentor early-career researchers, and engage with dynamic, interdisciplinary networks involving academic, industrial, and regulatory
-
details to three reference persons. Full publication list. Copy of passport, PhD diploma, and MSc transcripts with grades. The application should be sent electronically to lisa.dobrosch@liu.se . Mark
-
involves a combination of molecular biology, genetics and translational oncology discovery. The candidate will lead efforts to generate organoid models from biopsy specimens derived from patients undergoing
-
. Dr. Wang's laboratory conducts cutting-edge research to understand the evolution of cancer transcriptomes through DNA-RNA dynamics, aiming to uncover mechanisms of cancer initiation, progression, and